Volume 27, Number 3—March 2021
Synopsis
Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa
Table 2
Magnitude and duration of hospitalization and movement of patients with RR TB, Western Cape, South Africa, 2012–2014*
Description | Overall, n = 2,878 | Cape Town, n = 1,878 | Outside Cape Town, n = 1,000 | p value† |
---|---|---|---|---|
Hospitalization in TB hospital, no. (%)
No. patients with >1 sample from a specialized TB hospital in the first year after RR TB diagnosis |
1,228 (42.7) |
545 (29.0) |
683 (68.3) |
<0.01 |
Moved to care outside TB hospital, no. (%)
No. patients with a sample from a TB hospital who had a subsequent sample from a non-TB hospital <3 mo after the most recent sample in the TB hospital |
837 (68.2) |
317 (58.2) |
520 (76.1) |
<0.01 |
Median length of TB hospital stay, d (IQR)
Median hospitalization period of patients who moved to care outside of a TB hospital in the first year after RR TB diagnosis |
99 (61–136) |
79 (50–118) |
108 (72–144) |
<0.01‡ |
Any movement, no. (%)
No. patients who had samples from >2 different facilities in first year after RR TB diagnosis |
1,765 (61.3) |
1,012 (53.9) |
753 (75.3) |
<0.01 |
Median no. of visits (IQR)
No. unique days with >1 laboratory sample in the first year after RR TB diagnosis |
9 (5–12) |
8 (4–12) |
10 (5–12) |
<0.01‡ |
Median total distance, km (IQR)
Total Euclidian distance between all facilities visited by each patient in the first year after RR TB diagnosis |
4.4 (0.0–41) |
1.5 (0.0–20) |
46.0 (0.2–122) |
<0.01‡ |
Median distance between consecutive visits, km (IQR) Median distance between facilities visited consecutively by each patient in the first year after RR TB diagnosis | 2.7 (0.0–19.8) | 1.4 (0.0–12.2) | 24.0 (0.2–64.8) | <0.01‡ |
*Patients without second-line resistance who attended >2 clinic visits. RR, rifampin-resistant; TB, tuberculosis. †χ2 p values of patients in Cape Town versus outside Cape Town. ‡p values determined by Wilcoxon rank-sum test.